{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:35:44Z","timestamp":1794436544142,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-025-01666-7","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:57:00Z","timestamp":1749535020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical pathological and molecular features of 100 patients with gastric-type cervical adenocarcinoma"],"prefix":"10.1186","volume":"20","author":[{"given":"Shangshu","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"issue":"10","key":"1666_CR1","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1089\/jwh.2011.3385","volume":"21","author":"O Adegoke","year":"2012","unstructured":"Adegoke O, Kulasingam S, Virnig B. Cervical cancer trends in the United States: a 35-year population-based analysis. J Women\u2019s Health. 2012;21(10):1031\u20137.","journal-title":"J Women's Health."},{"issue":"1","key":"1666_CR2","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA: Cancer J Clin."},{"issue":"10","key":"1666_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1055\/a-1545-4279","volume":"81","author":"AK H\u00f6hn","year":"2021","unstructured":"H\u00f6hn AK, Brambs CE, Hiller GGR, May D, Schmoeckel E, Horn LC. 2020 WHO classification of female genital tumors. Geburtshilfe Frauenheilkd. 2021;81(10):1145\u201353.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"4","key":"1666_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/PAS.0000000000001224","volume":"43","author":"S Stolnicu","year":"2019","unstructured":"Stolnicu S, Hoang L, Chiu D, Hanko-Bauer O, Terinte C, Pesci A, et al. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC). Am J Surg Pathol. 2019;43(4):466\u201374.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1666_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/PAP.0b013e31829c2d66","volume":"20","author":"Y Mikami","year":"2013","unstructured":"Mikami Y, McCluggage WG. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions. Adv Anat Pathol. 2013;20(4):227\u201337.","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"1666_CR6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/PGP.0000000000000665","volume":"39","author":"A Hodgson","year":"2020","unstructured":"Hodgson A, Howitt BE, Park KJ, Lindeman N, Nucci MR, Parra-Herran C. Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior. International journal of gynecological pathology\u202f: official journal of the International Society of Gynecological Pathologists. 2020;39(6):578\u201386.","journal-title":"International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists"},{"issue":"12","key":"1666_CR7","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1038\/s41379-019-0305-x","volume":"32","author":"S Garg","year":"2019","unstructured":"Garg S, Nagaria TS, Clarke B, Freedman O, Khan Z, Schwock J, et al. Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing. Mod Pathol. 2019;32(12):1823\u201333.","journal-title":"Mod Pathol"},{"issue":"1","key":"1666_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ygyno.2019.01.022","volume":"153","author":"S Nishio","year":"2019","unstructured":"Nishio S, Mikami Y, Tokunaga H, Yaegashi N, Satoh T, Saito M, et al. Analysis of gastric-type mucinous carcinoma of the uterine cervix - An aggressive tumor with a poor prognosis: A multi-institutional study. Gynecol Oncol. 2019;153(1):13\u20139.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1666_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/bjc.2012.578","volume":"108","author":"SY Liao","year":"2013","unstructured":"Liao SY, Rodgers WH, Kauderer J, Darcy KM, Carter R, Susumu N, et al. Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study. Br J Cancer. 2013;108(3):613\u201320.","journal-title":"Br J Cancer"},{"issue":"3","key":"1666_CR10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ygyno.2022.10.003","volume":"167","author":"S Ehmann","year":"2022","unstructured":"Ehmann S, Sassine D, Straubhar AM, Praiss AM, Aghajanian C, Alektiar KM, et al. Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers. Gynecol Oncol. 2022;167(3):458\u201366.","journal-title":"Gynecol Oncol"},{"issue":"11","key":"1666_CR11","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1097\/PAS.0000000000000532","volume":"39","author":"YS Karamurzin","year":"2015","unstructured":"Karamurzin YS, Kiyokawa T, Parkash V, Jotwani AR, Patel P, Pike MC, et al. Gastric-type Endocervical Adenocarcinoma: An Aggressive Tumor With Unusual Metastatic Patterns and Poor Prognosis. Am J Surg Pathol. 2015;39(11):1449\u201357.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1666_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/01.pap.0000201828.92719.f3","volume":"13","author":"CJ O'Neill","year":"2006","unstructured":"O\u2019Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol. 2006;13(1):8\u201315.","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"1666_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1365-2559.2010.03632.x","volume":"57","author":"O Houghton","year":"2010","unstructured":"Houghton O, Jamison J, Wilson R, Carson J, McCluggage WG. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection. Histopathology. 2010;57(3):342\u201350.","journal-title":"Histopathology"},{"issue":"5","key":"1666_CR14","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/PAS.0000000000000578","volume":"40","author":"C Carleton","year":"2016","unstructured":"Carleton C, Hoang L, Sah S, Kiyokawa T, Karamurzin YS, Talia KL, et al. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas. Am J Surg Pathol. 2016;40(5):636\u201344.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1666_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00432-018-2817-z","volume":"145","author":"VD Li","year":"2019","unstructured":"Li VD, Li KH, Li JT. TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database. J Cancer Res Clin Oncol. 2019;145(3):625\u201336.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"1666_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100148","volume":"36","author":"S Wang","year":"2023","unstructured":"Wang S, Zhou X, Niu S, Chen L, Zhang H, Chen H, et al. Assessment of HER2 in Gastric-Type Endocervical Adenocarcinoma and its Prognostic Significance. Mod Pathol. 2023;36(6): 100148.","journal-title":"Mod Pathol"},{"key":"1666_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ygyno.2024.01.019","volume":"182","author":"KH Choi","year":"2024","unstructured":"Choi KH, Lee HC, Kim YS, Park W, Kim YB, Jung W, et al. Diagnostic assessments and treatment results of well-differentiated gastric-type adenocarcinoma of the uterine cervix (Adenoma malignum): A multicenter retrospective analysis of KROG 22\u201303 study. Gynecol Oncol. 2024;182:45\u201350.","journal-title":"Gynecol Oncol"},{"issue":"20","key":"1666_CR18","first-page":"1856","volume":"385","author":"N Colombo","year":"2021","unstructured":"Colombo N, Dubot C, Lorusso D, Caceres MV, Hasegawa K, Shapira-Frommer R, et al. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical. Cancer. 2021;385(20):1856\u201367.","journal-title":"Cancer"},{"issue":"6","key":"1666_CR19","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2024.35.e105","volume":"35","author":"MH Baek","year":"2024","unstructured":"Baek MH, Chen L, Tekin C, Cristescu R, Jin XY, Shao C, et al. Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer. Journal of gynecologic oncology. 2024;35(6): e105.","journal-title":"Journal of gynecologic oncology"},{"issue":"6","key":"1666_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131403","volume":"10","author":"P Wu","year":"2015","unstructured":"Wu P, Wu D, Li L, Chai Y, Huang J. PD-L1 and Survival in Solid Tumors: A Meta-Analysis. PLoS ONE. 2015;10(6): e0131403.","journal-title":"PLoS ONE"},{"key":"1666_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.572203","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, Yang Q. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1\/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis. Front Oncol. 2020;10: 572203.","journal-title":"Front Oncol"},{"key":"1666_CR22","doi-asserted-by":"publisher","first-page":"37933","DOI":"10.1038\/srep37933","volume":"6","author":"M Zhang","year":"2016","unstructured":"Zhang M, Dong Y, Liu H, Wang Y, Zhao S, Xuan Q, et al. The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients. Sci Rep. 2016;6:37933.","journal-title":"Sci Rep"},{"issue":"25","key":"1666_CR23","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan M, Hopkins A, Jaffee EM. Tumor Mutational Burden and Response Rate to PD-1 Inhibition. N Engl J Med. 2017;377(25):2500\u20131.","journal-title":"N Engl J Med"},{"issue":"6349","key":"1666_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science (New York, NY). 2017;357(6349):409\u201313.","journal-title":"Science (New York, NY)"},{"issue":"1","key":"1666_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/21645515.2019.1631136","volume":"16","author":"M Lee","year":"2020","unstructured":"Lee M, Samstein RM, Valero C, Chan TA, Morris LGT. Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy. Hum Vaccin Immunother. 2020;16(1):112\u20135.","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"1666_CR26","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","volume":"35","author":"AR Laury","year":"2011","unstructured":"Laury AR, Perets R, Piao H, Krane JF, Barletta JA, French C, et al. A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol. 2011;35(6):816\u201326.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1666_CR27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/PGP.0b013e3182a54afa","volume":"33","author":"A Yemelyanova","year":"2014","unstructured":"Yemelyanova A, Gown AM, Wu LS, Holmes BJ, Ronnett BM, Vang R. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations. International journal of gynecological pathology\u202f: official journal of the International Society of Gynecological Pathologists. 2014;33(5):492\u20139.","journal-title":"International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists"},{"issue":"6","key":"1666_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/PAP.0b013e318271a382","volume":"19","author":"NG Ord\u00f3\u00f1ez","year":"2012","unstructured":"Ord\u00f3\u00f1ez NG. Value of PAX2 immunostaining in tumor diagnosis: a review and update. Adv Anat Pathol. 2012;19(6):401\u20139.","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"1666_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/PGP.0b013e318257df46","volume":"32","author":"A Shukla","year":"2013","unstructured":"Shukla A, Thomas D, Roh MH. PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia. International journal of gynecological pathology\u202f: official journal of the International Society of Gynecological Pathologists. 2013;32(1):116\u201321.","journal-title":"International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists"},{"issue":"2","key":"1666_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/PAS.0b013e3181c89c98","volume":"34","author":"JT Rabban","year":"2010","unstructured":"Rabban JT, McAlhany S, Lerwill MF, Grenert JP, Zaloudek CJ. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma. Am J Surg Pathol. 2010;34(2):137\u201346.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1666_CR31","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/01.pas.0000213434.91868.b0","volume":"31","author":"A Kojima","year":"2007","unstructured":"Kojima A, Mikami Y, Sudo T, Yamaguchi S, Kusanagi Y, Ito M, et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol. 2007;31(5):664\u201372.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1666_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/PAP.0000000000000095","volume":"23","author":"WG McCluggage","year":"2016","unstructured":"McCluggage WG. Recent Developments in Non-HPV-related Adenocarcinomas of the Lower Female Genital Tract and Their Precursors. Adv Anat Pathol. 2016;23(1):58\u201369.","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"1666_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.prp.2012.12.003","volume":"209","author":"Y Mikami","year":"2013","unstructured":"Mikami Y, Minamiguchi S, Teramoto N, Nagura M, Haga H, Konishi I. Carbonic anhydrase type IX expression in lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix. Pathol Res Pract. 2013;209(3):173\u20138.","journal-title":"Pathol Res Pract"},{"key":"1666_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13000-015-0245-9","volume":"10","author":"K N\u011bmejcov\u00e1","year":"2015","unstructured":"N\u011bmejcov\u00e1 K, Cibula D, Dundr P. Expression of HNF-1\u03b2 in cervical carcinomas: an immunohistochemical study of 155 cases. Diagn Pathol. 2015;10:8.","journal-title":"Diagn Pathol"},{"issue":"3","key":"1666_CR35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/PAP.0000000000000067","volume":"22","author":"E Vakiani","year":"2015","unstructured":"Vakiani E. HER2 testing in gastric and gastroesophageal adenocarcinomas. Adv Anat Pathol. 2015;22(3):194\u2013201.","journal-title":"Adv Anat Pathol"},{"issue":"7","key":"1666_CR36","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/gut.2009.198499","volume":"59","author":"AD Beggs","year":"2010","unstructured":"Beggs AD, Latchford AR, Vasen HF, Moslein G, Alonso A, Aretz S, et al. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut. 2010;59(7):975\u201386.","journal-title":"Gut"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01666-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01666-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01666-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:57:01Z","timestamp":1749535021000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01666-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1666"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01666-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6295926\/v1","asserted-by":"object"}]},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The National Cancer Center\/Cancer Hospital Ethics Committee, Chinese Academy of Medical Sciences, and Peking Union Medical College approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}